Table 1.
Baseline Characteristics of the EPIC Study
| Characteristic | (N = 21) |
|---|---|
| Mean Age, Years (Range) | 77 (59 – 91) |
| Males, N (%) | 10 (48) |
| Ethnicity, N (%) | |
| Asian | 19 (90) |
| Caucasian | 2 (10) |
| Laterality, N (%) | |
| Unilateral | 16 (76) |
| Bilateral | 5 (24) |
| Prior Treatment, N (%) | |
| Prior Anti-VEGF | 11 (52) |
| Prior ML | 1 (4) |
| Prior PDT | 1 (4) |
| None (Treatment-Naïve) | 10 (48) |
| Median Visual Acuity (Range) | 20/40 (20/200 – 20/16) |
| Mean ETDRS Letters (Range) | 65.7 (30 – 89) |
| Mean Central Foveal Thickness, (μM) | 283 (164 – 550) |
VEGF vascular endothelial growth factor, ML macular laser, PDT Photodynamic therapy, ETDRS Early Treatment Diabetic Retinopathy Study, μm micrometers, n number